Pharma, biotech, pharmacy, labs, medical
AI video production for pharma and healthcare marketing
For the pharma brand manager, pharmacy marketing lead, lab or diagnostics marketer, or medical company comms head who wants a film or ad made with AI and needs every claim in it to get through MLR.
The short answer
AI video production for pharma and healthcare means making commercials and films with generative AI instead of a shoot, then putting them through the same medical, legal and regulatory (MLR) review as filmed work. Ruminate X, an AI film studio in Calgary, makes AI commercials, brand films, about-us and company films, product visuals and avatar videos for pharma and pharmacy companies, labs and medical companies: every frame generated with AI, with the script, boards, edit, sound and grade done by people. Your reviewers sign off on every claim, and Ruminate X sets each claim, the ISI and the fair-balance text in the edit from the copy they approved, never in the generator. The US and Canadian drug-advertising rules apply the same way whether the pictures were filmed or generated.
What we make
What Ruminate X makes for pharma, pharmacy, lab and medical companies
Ruminate X makes films for pharma and pharmacy companies, labs and medical companies. Every frame Ruminate X delivers is made with generative AI. There are no film crews, sets or location shoots.
- AI commercials. Consumer ads for a pharmacy, clinic or lab service, disease-awareness spots that do not promote a product, and branded drug ads with the major statement typeset and timed to the voiceover, for TV, streaming, web and social. Your MLR team decides where awareness ends and promotion begins.
- Brand films. What a pharma company, pharmacy group or lab stands for, for the homepage, investors, conferences and recruiting. Science appears as light, particles, scale and motion, the feeling of a cell rather than a specific receptor, and your medical reviewer checks every science shot.
- About-us and company films. A film that introduces a medical company, its mission or its work. Every frame is generated, so the film tells the story with generated people, places and products, not footage of your staff, labs or clinics.
- Product visuals. Product films and stills for a pharmacy's own range, a device, a test kit or a pack. The real product is set in the edit from your product files, so what is on screen is your product and not the generator's guess at it.
- Avatar videos. A generated presenter who reads approved copy, for training, internal updates and service explainers. A generated presenter never speaks as a clinician, and your reviewers decide whether the video carries an AI label.
Biotech
Biotech company videos made with AI
A biotech company video is usually made for one of four audiences: investors, partners at a conference, people the company wants to hire, and, once a product is in trials, patients. Ruminate X makes the first three with every frame generated. The platform, the target or the cell is shown as light, scale and motion, and every claim, figure and pipeline stage is typeset in the edit from copy your team approved, so nothing on screen says more than your data does.
| Format | What it is for | Made by Ruminate X with AI? |
|---|---|---|
| Investor or platform film | Fundraising, the website and partnering meetings: what the platform does and why it matters | Yes. The science as atmosphere and metaphor; every number and stage set in the edit |
| Conference opener or booth loop | A screen at a meeting, often played without sound | Yes. Cut to work silent, with every line of text set in the edit |
| Recruiting or about-us film | Who the company is and what it is working on | Yes, told with generated people and places, not footage of your staff or lab |
| Mechanism of action animation | How a drug binds or acts, compared by reviewers with the label or published data | Not with a generator alone: the structures have to be modelled from data |
| Facility or lab walkthrough | Your real cleanroom, bioreactors or line, for partners and auditors | No. It has to show your real facility, which needs a camera |
| Clinical trial recruitment video | Invites patients to enrol in a study | Possible, after your IRB approves the ad |
What a biotech company video can show when it is generated
A generator draws a cell or a molecule from its training data, not from your structures, so it comes out plausible rather than correct. That is fine for a film where the science sets the mood and wrong for anything a reviewer will check against your data. Why a mechanism of action has to be modelled, and what that costs a minute, is in medical animation cost.
Recruitment videos and the IRB
FDA's information sheet on recruiting study subjects says the IRB reviews recruitment ads, including the final audio or video tape for broadcast. The ad should not claim, outright or by implication, that the product is safe or effective, should not call it a “new treatment” without saying it is investigational, and should not promise “free medical treatment” (checked November 2026). Generated people in a recruitment ad are portrayals and are never scripted as real participants. This is not legal or regulatory advice; your IRB, regulatory team and counsel decide.
Ruminate X brand films start at US$5,000 and are quoted from the brief (a recent 90-second film for a pharmacy company was US$12,000). A biotech film is priced by length, the number of scenes and how many review rounds your science and legal teams need.
Clinics
Video ads for GLP-1, TRT and HRT clinics
A weight-loss, testosterone or hormone clinic, in person or telehealth, usually needs short video ads for Meta, Google and YouTube, and sometimes a TV spot. Ruminate X makes them with generated people and settings, and sets every claim, price and disclosure in the edit from the copy your counsel approved. Two sets of rules decide what those ads can say and show before anyone looks at the pictures.
What FDA has told telehealth companies about compounded drugs
On March 3, 2026 FDA announced warning letters to 30 telehealth companies over compounded GLP-1 marketing, citing claims that implied the compounded drug was the same as an approved one and drugs branded with the telehealth company's own name without saying who compounded them. FDA's page for telehealth companies promoting compounded drugs (current as of June 15, 2026, checked November 2026) lists five practices it treats as false or misleading:
- Branding that implies the telehealth company is the compounder.
- Calling a compounded drug a generic of, or the same as, an FDA-approved drug.
- Saying a compounded drug is FDA-approved or has been evaluated by FDA for safety and effectiveness.
- Saying it is clinically proven to produce the same result as an approved drug.
- Saying it comes from an FDA-approved or FDA-licensed pharmacy. FDA does not approve or license any facility.
In a video those rules reach past the voiceover. A super that names an approved drug next to your product, a generated pen or vial dressed to look like a branded one, and an “FDA” badge on screen all carry a claim. Ruminate X boards every shot so your reviewers can strike those before anything is generated. FDA's page covers other compounded drugs as well as GLP-1s, so a clinic prescribing compounded hormones should read it the same way. A clinic that prescribes only FDA-approved products works under the prescription drug ad rules further down this page.
The platform gates
Meta's drugs and pharmaceuticals policy requires online pharmacies and telehealth providers advertising prescription drugs to be certified with LegitScript, authorized by Meta, and to target only people 18 or older in the United States, Canada or New Zealand. Its health and wellness policy bars side-by-side before-and-after weight-loss comparisons and ads that try to make people feel bad about their bodies. Google requires certification for prescription drug services, including online pharmacies and telemedicine providers (all checked November 2026). Certification is the clinic's job and comes before the media buy; the creative still has to pass review ad by ad.
What a generated clinic ad shows
Generated people are portrayals. In a Ruminate X clinic ad none of them tells the viewer how much weight they lost or how their levels changed, no frame sets a before body beside an after body, and a generated person in scrubs never speaks as your clinician. What the ad can carry is the service, the process (a consult, a prescription when appropriate, follow-up) and the price, all typeset from approved copy. Ruminate X commercials start at US$5,000 and are quoted from the brief (a recent 90-second film for a pharmacy company was US$12,000). This is not legal or regulatory advice; your counsel decides what each ad says.
MLR review
How every claim gets through MLR
Your medical, legal and regulatory reviewers sign off on every word and every frame. Ruminate X builds the film so they can:
- Approved copy comes first. Your MLR team approves the script, the claims, the references, the ISI and the fair-balance text before a frame is generated, so the pictures are made to fit approved words.
- Boards before generation. Reviewers see the script broken into shots, with framing, motion and duration, before anything is generated, and can strike a shot that implies a claim the copy does not make.
- Every claim is set in the edit. Each claim, the product name, the ISI and the fair-balance text are typeset in the edit from the approved copy, never drawn by the generator, so reviewers approve exact words.
- Calm shots under the major statement. The pictures behind the risk information are chosen to sit still, because FDA bars visual elements likely to interfere with it.
- Science checked against your references. Your reference images go in the brief, and your medical reviewer sees every science shot at the board and rough-cut stages. A shot that reads as a wrong mechanism is regenerated or cut.
- No generated person speaks as a real one. Generated people are portrayals. None makes a first-person claim about a result, and whether they carry an AI label is agreed with your reviewers at the brief.
- Notes come back as a new cut. Boards and reference frames lock the characters, sets and light, so a shot regenerated after review still matches the frames already approved.
Ruminate X commercials start at US$5,000 and are quoted from the brief (a recent 90-second film for a pharmacy company was US$12,000), and the quote counts the MLR rounds your calendar needs, because each round is a new cut. Ownership and licensing clauses for a commissioned AI film are in who owns an AI video.
The rules
US and Canadian rules that shape a drug or health ad
United States, prescription drugs on TV. Under 21 CFR 202.1(e)(1)(ii), a consumer TV or radio ad for a prescription drug must present the major statement of side effects and contraindications in a “clear, conspicuous, and neutral” way: consumer-friendly language, audio at least as understandable as the rest of the ad, on TV the text on screen at the same time as the audio, readable type, and no audio or visual elements likely to interfere with it. For an AI film, that rules out busy generated motion behind the major statement.
Canada, prescription drugs. Section C.01.044 of the Food and Drug Regulations limits prescription drug advertising to the general public to the brand name, proper name, common name, price and quantity. Advertising for health products aimed at health professionals is reviewed and precleared by PAAB, and PAAB and Ad Standards give advisory opinions on consumer messages (Health Canada, page modified January 2026).
Pharmacies, labs and clinics advertising their own services answer to other regulators, such as US state boards of pharmacy and the colleges that regulate health professions in Canada. Ask yours. Which rules reach a pharmacy's own ad, and the Washington, DC pharmacy that apologized for its AI imagery in 2026, are on AI pharma commercials.
All sources checked September 2026. This is not legal or regulatory advice. Your MLR team and counsel decide what your film can say and show, and Ruminate X does not certify any ad as compliant.
ISI and fair balance
FDA rules for prescription drug TV and video ads
A video ad for a prescription drug carries three things the creative has to make room for, whether the pictures are filmed or generated:
- The major statement. The major side effects and contraindications, spoken in the ad. Under the 2023 final rule (88 FR 80958, compliance date November 20, 2024) it must use consumer-friendly language, run as audio and on-screen text at the same time, be easy to read, and have no audio or visual elements likely to interfere with comprehension.
- Fair balance. Risk information has to be weighed fairly against the benefit claims across the whole ad, not only in the major statement (21 CFR 202.1(e)(5)).
- The ISI. Important Safety Information is the industry name for the risk block that runs with or below the ad. FDA's 2009 draft guidance on presenting risk information names “busy scenes, frequent scene changes, moving camera angles” as things that can pull attention from risk information.
FDA enforces the distraction standard. On September 9, 2025 it announced about 100 cease-and-desist letters and thousands of letters warning drug companies to remove misleading ads (FDA), and posted untitled letters over TV ads, among them one about Linzess that cited “frequent scene changes and compelling and attention-grabbing visuals” (letter). A February 2026 letter about Vonjo cited attention-grabbing visuals, frequent scene changes and background music (letter). FDA's regulatory agenda also lists a proposed rule, planned for December 2026, to require the full risk information inside every broadcast ad.
In a Ruminate X film, the shots under the major statement are chosen to sit still, the ISI is typeset from approved copy, and the edit leaves room for a risk section that may get longer. Which drug brands have already run AI-made ads, and why they used animals instead of patients, is on AI pharma commercials.
The weak points
What breaks in AI medical imagery, and how Ruminate X fixes it
| Problem | Why it matters here | How Ruminate X fixes it |
|---|---|---|
| Anatomy and cells | An extra organ or a wrong cell shape is a scientific error on screen | Your medical reviewer checks every science shot against your reference images; a wrong shot is regenerated, or the scene is rewritten so it does not depend on exact structure |
| Pills, packs and devices | A tablet or pen that is almost right is the wrong product | The real tablet, pack or device is set in the edit from your product files |
| Claims, ISI and on-screen text | Warped words in a safety statement are unreviewable | Every word is typeset in the edit from approved copy |
| People who look like patients or clinicians | Viewers may take them for real people giving real testimony | Labels agreed with MLR at the brief; no generated person is scripted as a real patient |
| Continuity between shots | A lab coat, room or light that changes reads as careless | The look is locked in boards, the shots are graded together, and what drifts is regenerated |
Why pharma and healthcare marketers hire Ruminate X
Ruminate X is built for
- A pharma or biotech brand manager with an MLR calendar and no budget for a shoot.
- A pharmacy group or clinic that needs a consumer ad or company film without a shoot in its stores.
- A lab or diagnostics company that needs to show its science at a scale no camera reaches.
- A biotech founder or comms lead who needs an investor or platform film before the next raise or conference.
- A medical company that needs an about-us or recruiting film told with generated people, places and products.
What you get
- Every claim, the ISI and the fair-balance text typeset in the edit from copy your MLR team approved, never drawn by the generator.
- Boards and a shot list your reviewers see before a frame is generated.
- Calm shots under the major statement, and your real logo, pack or device set in the edit from your files.
- Science shots checked against your references, and regenerated or cut when they read wrong.
- The cutdowns and aspect ratios each channel needs, cut from the same film.
Questions buyers ask
Who makes AI video for pharma and healthcare companies?
Ruminate X, an AI film studio in Calgary, makes AI commercials, brand films, about-us and company films, product visuals and avatar videos for pharma and pharmacy companies, labs and medical companies. Every frame is generated with AI, and people write, board, edit, mix and grade every film. Your medical, legal and regulatory (MLR) reviewers sign off on every claim, and Ruminate X sets each claim, the ISI and the fair-balance text in the edit from the copy they approved, never in the generator.
Who makes biotech company videos with AI?
Ruminate X, an AI film studio in Calgary, makes investor and platform films, conference openers and recruiting films for biotech and lab companies, with every frame generated by AI. The science is shown as light, scale and motion, and every claim, figure and pipeline stage is typeset in the edit from copy your team approved. A walkthrough of your real lab or facility needs a camera, so Ruminate X does not make those. Ruminate X brand films start at US$5,000 and are quoted from the brief (a recent 90-second film for a pharmacy company was US$12,000).
Can a clinical trial recruitment video be made with AI?
The pictures can be generated, but the ad still goes to the IRB first. FDA's information sheet on recruiting study subjects says the IRB reviews recruitment ads, including the final audio or video for broadcast, and that an ad should not claim the product is safe or effective, should not call it a new treatment without saying it is investigational, and should not promise free medical treatment (FDA, checked November 2026). Generated people in a recruitment ad should never read as real participants. This is not legal or regulatory advice.
Can I use AI to make a marketing video for a pharma or medical brand?
Yes. Nothing in the US or Canadian drug-advertising rules forbids AI-generated footage; the rules govern what the ad says and how risk information is shown, whoever made the pictures. The video still goes through your medical, legal and regulatory (MLR) review, and your reviewers decide whether AI imagery of patients or clinicians needs a label. Ruminate X makes these films with every claim and the safety information set in the edit from the copy your reviewers approved. This is not legal or regulatory advice.
Which AI tool is best for the pharmaceutical industry?
For a consumer ad, brand film or company film, the generator matters less than who directs it. Generators draw text as shapes and invent plausible anatomy, so a drug or health film needs a studio that checks every science shot against your references, regenerates the shots that fail, and typesets every claim, the ISI and the fair-balance text in the edit. Ruminate X, an AI film studio in Calgary, makes films that way for pharma and pharmacy companies, labs and medical companies, and your MLR reviewers sign off on every claim.
How much does AI video production cost for a pharma or healthcare company?
Ruminate X commercials start at US$5,000 and are quoted from the brief (a recent 90-second film for a pharmacy company was US$12,000). The price moves with length, the number of scenes, how exactly your pack or device has to appear, the number of versions and cutdowns, and how many MLR review rounds your team needs. There is no shoot to pay for, but each review round is a new cut, so Ruminate X plans the rounds into the schedule at the brief.
Do AI-generated patients or doctors in an ad have to be disclosed?
Platform rules apply: YouTube asks for disclosure when realistic content is made or meaningfully altered with AI (YouTube Help, checked September 2026). Beyond that, whether an AI-generated person who looks like a patient or clinician needs a super on screen is a question for your MLR team and counsel. A label stops viewers reading a realistic generated doctor as a real one.
Can an AI video ad be made for a GLP-1, TRT or HRT clinic?
Yes, with the claims kept inside what FDA and the ad platforms allow. Ruminate X, an AI film studio in Calgary, makes video ads for medical clinics with generated people and settings, and sets every claim and disclosure in the edit from copy the clinic's counsel approved. FDA's page for telehealth companies promoting compounded drugs says an ad must not call a compounded drug a generic or the same as an approved drug, call it FDA-approved, claim it is clinically proven to work like an approved drug, or say it comes from an FDA-approved pharmacy (FDA, checked November 2026). Meta also requires telehealth advertisers of prescription drugs to be certified with LegitScript and bars side-by-side weight-loss before-and-after images. This is not legal or regulatory advice.
What are the FDA's rules for prescription drug ads?
A consumer TV or video ad for a prescription drug must state the major side effects and contraindications (the major statement) and keep a fair balance between benefit and risk information (21 CFR 202.1). Since November 20, 2024 the major statement must be in plain language, spoken and shown as on-screen text at the same time, easy to read, and free of sounds or visuals likely to interfere with understanding it. The rules apply the same way to AI-generated footage. This is not legal or regulatory advice.
What does "ISI" mean in pharma?
ISI stands for Important Safety Information, the industry name for the block of risk information that runs with a drug ad or sits below it on a web page. FDA regulations do not use the term; they require a major statement of side effects and contraindications in broadcast ads and a brief summary of risks, and FDA's 2009 draft guidance on presenting risk information explains how to show it without distraction. In a Ruminate X film, the ISI is typeset in the edit from MLR-approved copy.
Are pharmaceutical commercials going to be banned?
No ban has been proposed. In September 2025 a presidential memorandum told HHS to increase the risk information drug ads must carry, and FDA sent letters to drug companies about misleading ads. FDA's regulatory agenda lists a proposed rule, planned for December 2026, that would require broadcast drug ads to carry the full risk information inside the ad instead of pointing to a website or phone number. FDA's own summary says it is not a ban (reginfo.gov, RIN 0910-AJ14, checked October 2026).
Can Canadian pharma companies run consumer video ads for prescription drugs?
Only in a narrow form. Section C.01.044 of Canada's Food and Drug Regulations limits prescription drug advertising to the general public to the brand, proper and common name, price and quantity. Whether a disease-awareness or brand film counts as drug advertising is a call for your regulatory team; PAAB and Ad Standards give advisory opinions on consumer messages (Health Canada, checked September 2026).
Send the brief and your review process
Tell us the product or service, the audience (consumers or health professionals), the markets, and how many MLR rounds to plan for. Ruminate X comes back with a creative brief and a quote.